| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Bipolar Disorder | 11 | 2019 | 744 | 2.74 | Why? |
| Schizophrenia | 9 | 2019 | 1018 | 2.00 | Why? |
| Gray Matter | 5 | 2018 | 150 | 1.76 | Why? |
| Fatty Acids, Omega-3 | 3 | 2018 | 306 | 1.60 | Why? |
| White Matter | 3 | 2018 | 369 | 1.59 | Why? |
| Brain | 11 | 2019 | 5133 | 1.55 | Why? |
| Cognition | 6 | 2019 | 1394 | 1.46 | Why? |
| Magnetic Resonance Imaging | 17 | 2019 | 6551 | 1.33 | Why? |
| Urinalysis | 2 | 2019 | 218 | 1.30 | Why? |
| Psychotic Disorders | 9 | 2018 | 924 | 1.23 | Why? |
| Scleroderma, Systemic | 7 | 2019 | 583 | 1.21 | Why? |
| Sex Characteristics | 4 | 2018 | 1120 | 1.18 | Why? |
| Cerebral Cortex | 2 | 2017 | 276 | 1.12 | Why? |
| Docosahexaenoic Acids | 3 | 2019 | 145 | 0.98 | Why? |
| Diffusion Magnetic Resonance Imaging | 3 | 2017 | 317 | 0.96 | Why? |
| Functional Neuroimaging | 2 | 2019 | 86 | 0.95 | Why? |
| Scleroderma, Diffuse | 2 | 2018 | 20 | 0.90 | Why? |
| Parietal Lobe | 2 | 2019 | 29 | 0.83 | Why? |
| Dientamoeba | 1 | 2019 | 1 | 0.82 | Why? |
| Dientamoebiasis | 1 | 2019 | 1 | 0.82 | Why? |
| Vascular Remodeling | 2 | 2018 | 99 | 0.82 | Why? |
| Cognitive Remediation | 1 | 2019 | 14 | 0.80 | Why? |
| Microscopy, Phase-Contrast | 1 | 2019 | 10 | 0.80 | Why? |
| Functional Laterality | 2 | 2018 | 57 | 0.78 | Why? |
| Amygdala | 1 | 2019 | 42 | 0.78 | Why? |
| Prefrontal Cortex | 3 | 2019 | 151 | 0.77 | Why? |
| Central Nervous System Agents | 1 | 2019 | 45 | 0.77 | Why? |
| Intestinal Diseases, Parasitic | 1 | 2019 | 34 | 0.77 | Why? |
| Basal Ganglia | 2 | 2017 | 49 | 0.75 | Why? |
| Vasomotor System | 1 | 2018 | 13 | 0.75 | Why? |
| Hot Flashes | 1 | 2018 | 20 | 0.75 | Why? |
| Hypocalcemia | 1 | 2020 | 120 | 0.74 | Why? |
| Depressive Disorder, Treatment-Resistant | 1 | 2019 | 99 | 0.71 | Why? |
| Object Attachment | 1 | 2019 | 125 | 0.70 | Why? |
| Pituitary Gland | 1 | 2018 | 65 | 0.69 | Why? |
| Intramolecular Oxidoreductases | 1 | 2017 | 38 | 0.69 | Why? |
| Macrophage Migration-Inhibitory Factors | 1 | 2017 | 39 | 0.68 | Why? |
| Arteriovenous Shunt, Surgical | 2 | 2018 | 93 | 0.67 | Why? |
| Vascular Patency | 1 | 2017 | 96 | 0.66 | Why? |
| Schizophrenic Psychology | 2 | 2019 | 198 | 0.66 | Why? |
| Temporal Lobe | 1 | 2017 | 83 | 0.65 | Why? |
| Child Behavior | 2 | 2018 | 266 | 0.65 | Why? |
| Sleep Hygiene | 1 | 2017 | 91 | 0.63 | Why? |
| Mood Disorders | 2 | 2019 | 431 | 0.62 | Why? |
| Veins | 1 | 2017 | 168 | 0.61 | Why? |
| Anxiety Disorders | 2 | 2019 | 2290 | 0.58 | Why? |
| Automation, Laboratory | 1 | 2018 | 536 | 0.58 | Why? |
| Television | 1 | 2017 | 224 | 0.57 | Why? |
| Calcium | 1 | 2020 | 708 | 0.57 | Why? |
| Blood Chemical Analysis | 1 | 2019 | 541 | 0.56 | Why? |
| Arteries | 1 | 2017 | 283 | 0.56 | Why? |
| Polychlorinated Dibenzodioxins | 3 | 2018 | 18 | 0.55 | Why? |
| Antidepressive Agents | 1 | 2019 | 509 | 0.53 | Why? |
| Limit of Detection | 2 | 2019 | 2698 | 0.53 | Why? |
| Hand | 1 | 2018 | 449 | 0.52 | Why? |
| Non-ST Elevated Myocardial Infarction | 1 | 2019 | 490 | 0.52 | Why? |
| Child Development | 2 | 2018 | 352 | 0.52 | Why? |
| Cognition Disorders | 1 | 2019 | 574 | 0.52 | Why? |
| RNA Polymerase III | 2 | 2017 | 18 | 0.52 | Why? |
| Troponin T | 1 | 2019 | 771 | 0.51 | Why? |
| Promoter Regions, Genetic | 1 | 2017 | 823 | 0.51 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.50 | Why? |
| Video Games | 1 | 2017 | 270 | 0.49 | Why? |
| Emotions | 4 | 2019 | 2418 | 0.48 | Why? |
| Brain Mapping | 5 | 2019 | 228 | 0.48 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.48 | Why? |
| Child Welfare | 1 | 2017 | 405 | 0.44 | Why? |
| Corpus Callosum | 2 | 2017 | 182 | 0.38 | Why? |
| Inducible T-Cell Co-Stimulator Protein | 1 | 2018 | 6 | 0.38 | Why? |
| Receptors, CXCR5 | 1 | 2018 | 35 | 0.38 | Why? |
| Liraglutide | 1 | 2018 | 47 | 0.37 | Why? |
| Sleep Wake Disorders | 2 | 2017 | 1463 | 0.36 | Why? |
| Incretins | 1 | 2018 | 61 | 0.35 | Why? |
| Algorithms | 4 | 2019 | 7346 | 0.35 | Why? |
| Hypertension, Pulmonary | 1 | 2017 | 970 | 0.35 | Why? |
| Lung Diseases, Fungal | 2 | 2020 | 167 | 0.35 | Why? |
| Endothelial Progenitor Cells | 1 | 2018 | 103 | 0.34 | Why? |
| Female | 58 | 2021 | 380317 | 0.33 | Why? |
| Lower Urinary Tract Symptoms | 1 | 2018 | 116 | 0.33 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.32 | Why? |
| Abatacept | 1 | 2018 | 192 | 0.32 | Why? |
| Obesity, Abdominal | 1 | 2018 | 167 | 0.32 | Why? |
| Eicosapentaenoic Acid | 2 | 2017 | 106 | 0.32 | Why? |
| Breast Implants | 1 | 2017 | 64 | 0.32 | Why? |
| Skin | 2 | 2018 | 2096 | 0.31 | Why? |
| Capillaries | 1 | 2018 | 257 | 0.31 | Why? |
| Male | 52 | 2021 | 367725 | 0.31 | Why? |
| Breast Feeding | 1 | 2017 | 1585 | 0.30 | Why? |
| Adult | 37 | 2021 | 244371 | 0.28 | Why? |
| Humans | 76 | 2021 | 930598 | 0.28 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.28 | Why? |
| Still's Disease, Adult-Onset | 1 | 2016 | 100 | 0.28 | Why? |
| Dietary Supplements | 1 | 2016 | 2251 | 0.27 | Why? |
| Rare Diseases | 1 | 2018 | 373 | 0.27 | Why? |
| Sleep | 1 | 2017 | 2695 | 0.26 | Why? |
| Machine Learning | 2 | 2019 | 4395 | 0.26 | Why? |
| Affect | 2 | 2019 | 549 | 0.26 | Why? |
| Middle Aged | 37 | 2021 | 270681 | 0.26 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.25 | Why? |
| Colchicine | 2 | 2020 | 730 | 0.25 | Why? |
| Cardiologists | 1 | 2018 | 366 | 0.25 | Why? |
| Image Processing, Computer-Assisted | 4 | 2018 | 1383 | 0.25 | Why? |
| Antirheumatic Agents | 3 | 2018 | 3023 | 0.25 | Why? |
| Th17 Cells | 1 | 2018 | 657 | 0.25 | Why? |
| Neuroimaging | 3 | 2019 | 1106 | 0.24 | Why? |
| Disease Progression | 4 | 2019 | 13580 | 0.24 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2018 | 4545 | 0.24 | Why? |
| Attention Deficit Disorder with Hyperactivity | 2 | 2018 | 441 | 0.23 | Why? |
| Aging | 2 | 2018 | 3581 | 0.23 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2018 | 698 | 0.23 | Why? |
| Renal Dialysis | 2 | 2018 | 4358 | 0.21 | Why? |
| Hydroxycholesterols | 1 | 2020 | 85 | 0.21 | Why? |
| Pericarditis | 1 | 2016 | 417 | 0.20 | Why? |
| Arthritis, Rheumatoid | 2 | 2018 | 2043 | 0.20 | Why? |
| Organ Size | 2 | 2018 | 384 | 0.20 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.20 | Why? |
| Statistics as Topic | 2 | 2017 | 370 | 0.20 | Why? |
| Neurobiology | 1 | 2019 | 12 | 0.20 | Why? |
| Seveso Accidental Release | 1 | 2018 | 7 | 0.20 | Why? |
| Atomoxetine Hydrochloride | 1 | 2018 | 10 | 0.19 | Why? |
| Dioxins | 1 | 2018 | 4 | 0.19 | Why? |
| Scleroderma, Limited | 1 | 2018 | 10 | 0.19 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.19 | Why? |
| Environmental Exposure | 3 | 2018 | 1558 | 0.19 | Why? |
| Oxyhemoglobins | 1 | 2018 | 30 | 0.19 | Why? |
| Feeding Methods | 1 | 2018 | 15 | 0.19 | Why? |
| Schizotypal Personality Disorder | 1 | 2018 | 12 | 0.19 | Why? |
| Arteriovenous Fistula | 1 | 2018 | 23 | 0.19 | Why? |
| Echocardiography, Doppler | 2 | 2018 | 269 | 0.19 | Why? |
| Intra-Abdominal Fat | 1 | 2021 | 227 | 0.18 | Why? |
| Child Nutritional Physiological Phenomena | 1 | 2018 | 40 | 0.18 | Why? |
| Language Tests | 1 | 2017 | 13 | 0.18 | Why? |
| Lung Diseases | 2 | 2021 | 2361 | 0.18 | Why? |
| Speech Disorders | 1 | 2018 | 55 | 0.18 | Why? |
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 96 | 0.18 | Why? |
| Social Adjustment | 1 | 2018 | 77 | 0.18 | Why? |
| Congresses as Topic | 1 | 2018 | 1347 | 0.18 | Why? |
| Adiposity | 1 | 2021 | 329 | 0.18 | Why? |
| Neuronal Plasticity | 1 | 2018 | 98 | 0.18 | Why? |
| Radiographic Image Enhancement | 1 | 2018 | 89 | 0.18 | Why? |
| Linear Models | 2 | 2019 | 1914 | 0.17 | Why? |
| Comprehension | 2 | 2018 | 259 | 0.17 | Why? |
| Autoantibodies | 4 | 2018 | 2094 | 0.17 | Why? |
| Appetite Regulation | 1 | 2017 | 14 | 0.17 | Why? |
| Irritable Mood | 1 | 2017 | 93 | 0.17 | Why? |
| Arm | 1 | 2018 | 159 | 0.17 | Why? |
| Pituitary-Adrenal System | 1 | 2018 | 135 | 0.17 | Why? |
| Corpus Striatum | 1 | 2017 | 49 | 0.17 | Why? |
| Bariatric Surgery | 1 | 2018 | 1298 | 0.17 | Why? |
| Birth Weight | 1 | 2018 | 250 | 0.16 | Why? |
| Receptors, Aryl Hydrocarbon | 1 | 2018 | 152 | 0.16 | Why? |
| Depression | 2 | 2018 | 14116 | 0.16 | Why? |
| Stress, Mechanical | 1 | 2017 | 143 | 0.16 | Why? |
| Menopause | 1 | 2018 | 136 | 0.16 | Why? |
| Drug Resistance | 1 | 2019 | 395 | 0.16 | Why? |
| Patient Care | 1 | 2018 | 1664 | 0.16 | Why? |
| Metaphor | 1 | 2017 | 71 | 0.16 | Why? |
| Lipoprotein(a) | 1 | 2017 | 92 | 0.16 | Why? |
| Rhinitis, Allergic, Seasonal | 1 | 2018 | 121 | 0.16 | Why? |
| Hypothalamo-Hypophyseal System | 1 | 2018 | 187 | 0.16 | Why? |
| Systole | 1 | 2017 | 252 | 0.16 | Why? |
| Automation | 1 | 2019 | 429 | 0.16 | Why? |
| Radiopharmaceuticals | 2 | 2018 | 763 | 0.16 | Why? |
| Environmental Pollutants | 2 | 2018 | 320 | 0.16 | Why? |
| Regional Blood Flow | 1 | 2017 | 172 | 0.16 | Why? |
| Positron-Emission Tomography | 2 | 2018 | 802 | 0.15 | Why? |
| Graft Occlusion, Vascular | 1 | 2017 | 105 | 0.15 | Why? |
| Cardiomyopathy, Hypertrophic | 1 | 2018 | 193 | 0.15 | Why? |
| Cerebellum | 1 | 2017 | 119 | 0.15 | Why? |
| Mental Disorders | 1 | 2019 | 6742 | 0.15 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.15 | Why? |
| Immunologic Memory | 1 | 2018 | 3362 | 0.15 | Why? |
| Hippocampus | 1 | 2018 | 237 | 0.15 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.15 | Why? |
| ROC Curve | 2 | 2019 | 6024 | 0.15 | Why? |
| Language | 2 | 2018 | 655 | 0.15 | Why? |
| Pseudomonas Infections | 1 | 2020 | 425 | 0.15 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.15 | Why? |
| Italy | 13 | 2021 | 38444 | 0.14 | Why? |
| Pseudomonas aeruginosa | 1 | 2020 | 652 | 0.14 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.14 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.14 | Why? |
| Complementary Therapies | 1 | 2018 | 280 | 0.14 | Why? |
| Treatment Outcome | 6 | 2021 | 51732 | 0.14 | Why? |
| Neurodevelopmental Disorders | 1 | 2019 | 284 | 0.14 | Why? |
| Habits | 1 | 2017 | 334 | 0.14 | Why? |
| Adolescent | 12 | 2020 | 86841 | 0.14 | Why? |
| Time | 1 | 2017 | 631 | 0.14 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.13 | Why? |
| Emergency Service, Hospital | 1 | 2019 | 14232 | 0.13 | Why? |
| Young Adult | 13 | 2020 | 93724 | 0.13 | Why? |
| Reference Values | 1 | 2017 | 795 | 0.13 | Why? |
| Fluorodeoxyglucose F18 | 2 | 2018 | 1153 | 0.13 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2018 | 319 | 0.13 | Why? |
| Aged | 19 | 2021 | 215776 | 0.13 | Why? |
| Autistic Disorder | 1 | 2017 | 253 | 0.13 | Why? |
| Evidence-Based Practice | 1 | 2019 | 693 | 0.13 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 669 | 0.13 | Why? |
| Quality of Life | 2 | 2019 | 9820 | 0.13 | Why? |
| Parents | 2 | 2017 | 2758 | 0.12 | Why? |
| Time Factors | 6 | 2019 | 31397 | 0.12 | Why? |
| Intestines | 1 | 2019 | 817 | 0.12 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.12 | Why? |
| Parenting | 1 | 2018 | 486 | 0.12 | Why? |
| Depressive Disorder, Major | 2 | 2016 | 852 | 0.12 | Why? |
| Gene Frequency | 1 | 2017 | 1210 | 0.12 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.11 | Why? |
| Weight Gain | 1 | 2017 | 552 | 0.11 | Why? |
| Epigenesis, Genetic | 1 | 2018 | 711 | 0.11 | Why? |
| Interpersonal Relations | 1 | 2019 | 926 | 0.11 | Why? |
| Pediatric Obesity | 1 | 2017 | 492 | 0.11 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.11 | Why? |
| Predictive Value of Tests | 3 | 2021 | 9537 | 0.11 | Why? |
| Tandem Mass Spectrometry | 1 | 2017 | 1031 | 0.11 | Why? |
| Psychiatric Status Rating Scales | 1 | 2017 | 1340 | 0.10 | Why? |
| Overweight | 1 | 2017 | 916 | 0.10 | Why? |
| Diagnostic Errors | 1 | 2017 | 865 | 0.10 | Why? |
| Pulmonary Artery | 1 | 2017 | 803 | 0.10 | Why? |
| Antipsychotic Agents | 1 | 2019 | 887 | 0.10 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.10 | Why? |
| Clinical Trials as Topic | 1 | 2019 | 7330 | 0.10 | Why? |
| Dermatitis, Atopic | 1 | 2018 | 714 | 0.10 | Why? |
| DNA Topoisomerases | 1 | 2018 | 2 | 0.10 | Why? |
| European Union | 2 | 2018 | 565 | 0.10 | Why? |
| Child | 6 | 2018 | 70012 | 0.10 | Why? |
| Autism Spectrum Disorder | 1 | 2017 | 587 | 0.09 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.09 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.09 | Why? |
| Cardiovascular Diseases | 2 | 2018 | 11497 | 0.09 | Why? |
| Case-Control Studies | 7 | 2020 | 17671 | 0.09 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.09 | Why? |
| Patient Compliance | 1 | 2018 | 1468 | 0.09 | Why? |
| Depressive Disorder | 1 | 2018 | 1236 | 0.09 | Why? |
| Silicones | 1 | 2017 | 26 | 0.09 | Why? |
| Prognosis | 7 | 2021 | 32490 | 0.09 | Why? |
| Biomarkers | 6 | 2020 | 23361 | 0.09 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.08 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.08 | Why? |
| Infant | 4 | 2018 | 30274 | 0.08 | Why? |
| Diarrhea | 1 | 2019 | 2743 | 0.08 | Why? |
| Vital Capacity | 1 | 2018 | 399 | 0.08 | Why? |
| Software | 1 | 2018 | 2501 | 0.08 | Why? |
| Endothelial Cells | 1 | 2017 | 2048 | 0.08 | Why? |
| Brief Psychiatric Rating Scale | 1 | 2005 | 30 | 0.08 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.08 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.08 | Why? |
| Feeding Behavior | 1 | 2018 | 1909 | 0.07 | Why? |
| Forced Expiratory Volume | 1 | 2018 | 632 | 0.07 | Why? |
| Feces | 1 | 2019 | 4235 | 0.07 | Why? |
| Lymphocyte Depletion | 1 | 2017 | 293 | 0.07 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.07 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.07 | Why? |
| Radiography, Thoracic | 1 | 2021 | 5486 | 0.07 | Why? |
| Severity of Illness Index | 7 | 2019 | 48226 | 0.07 | Why? |
| Infant, Newborn | 4 | 2018 | 23105 | 0.07 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.07 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.06 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.06 | Why? |
| Lung | 2 | 2021 | 31049 | 0.06 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.06 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.06 | Why? |
| Women's Health | 2 | 2018 | 444 | 0.06 | Why? |
| Smokers | 1 | 2018 | 550 | 0.06 | Why? |
| Fibroblast Growth Factor 2 | 1 | 2002 | 77 | 0.06 | Why? |
| Chi-Square Distribution | 1 | 2005 | 961 | 0.06 | Why? |
| Patient Admission | 1 | 2019 | 5250 | 0.06 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.06 | Why? |
| Analysis of Variance | 1 | 2005 | 950 | 0.06 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.06 | Why? |
| Europe | 3 | 2019 | 12702 | 0.06 | Why? |
| Greece | 1 | 2018 | 2091 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.05 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.05 | Why? |
| Child, Preschool | 4 | 2018 | 36283 | 0.05 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.05 | Why? |
| Sex Distribution | 1 | 2018 | 2083 | 0.05 | Why? |
| Recurrence | 1 | 2021 | 3675 | 0.05 | Why? |
| Health Status Disparities | 1 | 2018 | 4072 | 0.05 | Why? |
| Switzerland | 1 | 2018 | 2738 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.05 | Why? |
| Teratogens | 1 | 2018 | 15 | 0.05 | Why? |
| Hep G2 Cells | 1 | 2020 | 391 | 0.05 | Why? |
| CA3 Region, Hippocampal | 1 | 2018 | 4 | 0.05 | Why? |
| Xenobiotics | 1 | 2018 | 37 | 0.05 | Why? |
| CA1 Region, Hippocampal | 1 | 2018 | 12 | 0.05 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.05 | Why? |
| Methylphenidate | 1 | 2018 | 36 | 0.05 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.05 | Why? |
| Pericardium | 1 | 2021 | 228 | 0.05 | Why? |
| Longitudinal Studies | 2 | 2018 | 9893 | 0.05 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.05 | Why? |
| DNA Topoisomerases, Type I | 1 | 2018 | 86 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.04 | Why? |
| Databases, Factual | 3 | 2018 | 6248 | 0.04 | Why? |
| Serotonin Plasma Membrane Transport Proteins | 1 | 2018 | 39 | 0.04 | Why? |
| Proof of Concept Study | 1 | 2020 | 696 | 0.04 | Why? |
| Raynaud Disease | 1 | 2018 | 86 | 0.04 | Why? |
| Coccidioidomycosis | 1 | 2017 | 47 | 0.04 | Why? |
| Cross-Sectional Studies | 4 | 2018 | 53120 | 0.04 | Why? |
| Spectroscopy, Near-Infrared | 1 | 2018 | 137 | 0.04 | Why? |
| Acute-Phase Proteins | 1 | 2018 | 177 | 0.04 | Why? |
| Fetal Development | 1 | 2018 | 173 | 0.04 | Why? |
| Models, Cardiovascular | 1 | 2018 | 153 | 0.04 | Why? |
| Hydrodynamics | 1 | 2018 | 177 | 0.04 | Why? |
| Leukemia | 1 | 2002 | 598 | 0.04 | Why? |
| France | 2 | 2018 | 12074 | 0.04 | Why? |
| Meals | 1 | 2018 | 205 | 0.04 | Why? |
| Gadolinium | 1 | 2018 | 318 | 0.04 | Why? |
| Histoplasmosis | 1 | 2017 | 83 | 0.04 | Why? |
| Maternal-Fetal Exchange | 1 | 2018 | 209 | 0.04 | Why? |
| Pattern Recognition, Automated | 1 | 2017 | 160 | 0.04 | Why? |
| Hand Strength | 1 | 2017 | 202 | 0.04 | Why? |
| Food Analysis | 1 | 2017 | 53 | 0.04 | Why? |
| Forensic Sciences | 1 | 2017 | 49 | 0.04 | Why? |
| Cryptococcosis | 1 | 2017 | 97 | 0.04 | Why? |
| Food Preferences | 1 | 2018 | 128 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2020 | 6543 | 0.04 | Why? |
| Death Certificates | 1 | 2017 | 130 | 0.04 | Why? |
| Nuclear Proteins | 1 | 2018 | 321 | 0.04 | Why? |
| Chemistry, Pharmaceutical | 1 | 2017 | 152 | 0.04 | Why? |
| Internationality | 1 | 2018 | 3297 | 0.04 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.04 | Why? |
| Community Health Centers | 1 | 2017 | 201 | 0.04 | Why? |
| Animals | 4 | 2020 | 78931 | 0.04 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.03 | Why? |
| Personality | 1 | 2017 | 277 | 0.03 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.03 | Why? |
| Stress, Physiological | 1 | 2018 | 378 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2018 | 954 | 0.03 | Why? |
| Pneumonia, Pneumocystis | 1 | 2017 | 322 | 0.03 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2017 | 669 | 0.03 | Why? |
| DNA Methylation | 1 | 2018 | 688 | 0.03 | Why? |
| Adolescent Behavior | 1 | 2018 | 400 | 0.03 | Why? |
| Pulmonary Aspergillosis | 1 | 2017 | 408 | 0.03 | Why? |
| Awareness | 1 | 2017 | 529 | 0.03 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.03 | Why? |
| Pregnancy | 3 | 2018 | 23879 | 0.03 | Why? |
| Sex Factors | 2 | 2018 | 11014 | 0.03 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.03 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.02 | Why? |
| Dexamethasone | 1 | 2020 | 2055 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Bayes Theorem | 1 | 2017 | 3237 | 0.02 | Why? |
| Residence Characteristics | 1 | 2017 | 1927 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Research | 1 | 2018 | 2115 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Putamen | 1 | 2003 | 24 | 0.02 | Why? |
| Globus Pallidus | 1 | 2003 | 34 | 0.02 | Why? |
| Family | 1 | 2018 | 2909 | 0.02 | Why? |
| Fibroblast Growth Factor 3 | 1 | 2002 | 1 | 0.02 | Why? |
| Fibroblast Growth Factor 4 | 1 | 2002 | 1 | 0.02 | Why? |
| Fibroblast Growth Factor 6 | 1 | 2002 | 1 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.02 | Why? |
| Fibroblast Growth Factor 1 | 1 | 2002 | 10 | 0.02 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.02 | Why? |
| Culture Media, Conditioned | 1 | 2002 | 66 | 0.02 | Why? |
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2003 | 184 | 0.02 | Why? |
| Tumor Cells, Cultured | 1 | 2002 | 254 | 0.02 | Why? |
| Immunoblotting | 1 | 2002 | 180 | 0.01 | Why? |
| Chromatography | 1 | 2002 | 112 | 0.01 | Why? |
| Fibroblast Growth Factors | 1 | 2002 | 119 | 0.01 | Why? |
| Proto-Oncogene Proteins | 1 | 2002 | 340 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Dose-Response Relationship, Drug | 1 | 2002 | 3776 | 0.01 | Why? |
| Cells, Cultured | 1 | 2002 | 5835 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| RNA, Messenger | 1 | 2002 | 5131 | 0.01 | Why? |
| Mice | 1 | 2002 | 21357 | 0.00 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 13720 | 0.00 | Why? |